4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-012351
Chief Financial Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2022-09-08 | Option exercise | +40,000 | $0.40 | $16,000 | 116,132 | D |
| Derivatives | |||||||
| Jeanmonod Patrik Chief Financial Officer | 2022-09-08 | Option exercise · Employee Stock Option (Right to Buy) | −40,000 | 202,661 | D | ||
Loading xslF345X03/doc4.xml…